However, since benign prostatic diseases could also present elevated PSA, specificity of PSA for PCa screening is relatively poor and could result in a large number of false positive cases (Nadler et al., 1995; Sindhwani and Wilson, 2005). The gene discussed is KLK3; the disease is posterior cortical atrophy.